SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: TRIS PHARMA, INC., TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS
Firm Income Reported for This Client
$790K
Not substituted for client expenses
Summary
TRIS PHARMA INC is an organization. Its political footprint includes $790K in lobbying-firm income reported for this client. Lobbying activity focuses on Pharmacy, Health Issues. Their largest government contract source is Department of Veterans Affairs at $0. Political activity spans from 2016 to 2026.